Treace Medical Concepts Statistics
Total Valuation
TMCI has a market cap or net worth of $574.38 million. The enterprise value is $561.70 million.
Important Dates
The next confirmed earnings date is Thursday, February 27, 2025, after market close.
| Earnings Date | Feb 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TMCI has 62.30 million shares outstanding. The number of shares has increased by 4.46% in one year.
| Current Share Class | 62.30M |
| Shares Outstanding | 62.30M |
| Shares Change (YoY) | +4.46% |
| Shares Change (QoQ) | +0.24% |
| Owned by Insiders (%) | 24.30% |
| Owned by Institutions (%) | 53.83% |
| Float | 47.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.82 |
| Forward PS | 2.58 |
| PB Ratio | 5.47 |
| P/TBV Ratio | 6.86 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.77 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.12, with a Debt / Equity ratio of 0.67.
| Current Ratio | 4.12 |
| Quick Ratio | 2.81 |
| Debt / Equity | 0.67 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.84 |
Financial Efficiency
Return on equity (ROE) is -50.69% and return on invested capital (ROIC) is -20.25%.
| Return on Equity (ROE) | -50.69% |
| Return on Assets (ROA) | -17.13% |
| Return on Capital (ROIC) | -20.25% |
| Revenue Per Employee | $393,141 |
| Profits Per Employee | -$119,231 |
| Employee Count | 516 |
| Asset Turnover | 0.90 |
| Inventory Turnover | 1.08 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.69% in the last 52 weeks. The beta is 0.69, so TMCI's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -28.69% |
| 50-Day Moving Average | 7.90 |
| 200-Day Moving Average | 7.00 |
| Relative Strength Index (RSI) | 66.02 |
| Average Volume (20 Days) | 326,381 |
Short Selling Information
The latest short interest is 2.32 million, so 3.73% of the outstanding shares have been sold short.
| Short Interest | 2.32M |
| Short Previous Month | 2.38M |
| Short % of Shares Out | 3.73% |
| Short % of Float | 4.93% |
| Short Ratio (days to cover) | 8.77 |
Income Statement
In the last 12 months, TMCI had revenue of $202.86 million and -$61.52 million in losses. Loss per share was -$0.99.
| Revenue | 202.86M |
| Gross Profit | 163.53M |
| Operating Income | -62.10M |
| Pretax Income | -63.68M |
| Net Income | -61.52M |
| EBITDA | -54.63M |
| EBIT | -62.10M |
| Loss Per Share | -$0.99 |
Full Income StatementBalance Sheet
The company has $82.80 million in cash and $70.12 million in debt, giving a net cash position of $12.68 million or $0.20 per share.
| Cash & Cash Equivalents | 82.80M |
| Total Debt | 70.12M |
| Net Cash | 12.68M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | 104.91M |
| Book Value Per Share | 1.68 |
| Working Capital | 119.34M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$32.43 million and capital expenditures -$10.77 million, giving a free cash flow of -$43.20 million.
| Operating Cash Flow | -32.43M |
| Capital Expenditures | -10.77M |
| Free Cash Flow | -43.20M |
| FCF Per Share | -$0.69 |
Full Cash Flow StatementMargins
Gross margin is 80.61%, with operating and profit margins of -30.61% and -30.33%.
| Gross Margin | 80.61% |
| Operating Margin | -30.61% |
| Pretax Margin | -30.33% |
| Profit Margin | -30.33% |
| EBITDA Margin | -26.93% |
| EBIT Margin | -30.61% |
| FCF Margin | n/a |
Dividends & Yields
TMCI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.46% |
| Shareholder Yield | -4.46% |
| Earnings Yield | -10.71% |
| FCF Yield | -7.52% |
Analyst Forecast
The average price target for TMCI is $8.84, which is -4.12% lower than the current price. The consensus rating is "Hold".
| Price Target | $8.84 |
| Price Target Difference | -4.12% |
| Analyst Consensus | Hold |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 9.05% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMCI has an Altman Z-Score of 2.66 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.66 |
| Piotroski F-Score | 2 |